|
Videos for facet biotech by viewCount Funny Video Page 1
Good Morning. It's Wednesday, March 10, 2010. At this hour, US equity futures are higher. Overseas, the Asian markets were mixed, while the European markets are mostly higher. Today's UPGRADES include: InterMune (ITMN) upgraded to Outperform from Market Perform at Wells Fargo. Analog Devices (ADI) upgraded to Outperform from Market Perform at Bernstein. Global Payments (GPN) upgraded to Positive from Neutral at Susquehanna. DOWNGRADES: J.Crew (JCG) downgraded to Hold from Buy at Citigroup.. Vale SA (VALE) downgraded to Neutral from Buy at UBS. FPIC Insurance (FPIC) downgraded to Perform from Outperform at Oppenheimer. Hot News: Abbott Labs (ABT) acquired Facet Biotech (FACT) for $27 per share, or approximately $450M, to enhance Abbott's early and mid-stage pharmaceutical pipeline. InterMune (ITMN) announced that the FDAs Pulmonary-Allergy Drugs Advisory Committee voted 9-3 to recommend approval of Esbriet for the treatment of patients with idiopathic pulmonary fibrosis to reduce decline in lung function. EA SPORTS, a label of Electronic Arts (ERTS), announced that EA SPORTS Active 2.0 is now in development and will be available this fall on PlayStation3 (SNE), Wii (NTDOY), the iPhone (AAPL) and the iPod touch. Acacia Research Corp. (ACTG) announced that a subsidiary has acquired rights to 48 US patents, 72 foreign counterparts, and associated applications from a leading international research institute. The patents cover various wireless and other communications ...
H&R Block's fiscal first-quarter loss widened slightly, as costs from a takeover more than offset other expense cuts and an unusual profit in business services. Biogen Idec said today it had offered to acquire Facet Biotech, a partner in developing multiple sclerosis and cancer drugs, in a deal valued at about $355 million. CIT Group said it has extended the contract of Chief Executive Jeffrey Peek for one year, even though his decisions to expand into risky businesses helped to push the lender to the brink of bankruptcy. Toshiba plans to bid for French nuclear group Areva's power transmission and distribution unit in a deal that could top $5 billion. Google announced that its China president, Kai-Fu Lee, is leaving the company to work on his own venture. Lee was the center of a legal fight when he left Microsoft in 2005 to join Google. The G20 will promise this weekend to keep economic support packages in place until recovery is certain and seek to reassure financial markets they have credible plans to withdraw the stimulus when appropriate.
3/10/2010-Shares of Facet Biotech Corp. (NASDAQ:FACT) are trading 66.2% higher to $26.94 Wednesday after Abbott Laboratories (NYSE:ABT) agreed to buy the biotechnology company for $27 a share, for a net transaction value of about $450 million, enhancing Abbott's early and mid stage pharmaceutical pipeline. The transaction is expected to close in the second quarter of 2010.
March 10, 2010: 8:15 AM ET --- US stock futures are trading higher Wednesday as investors await M&A news and wholesale inventory data. Wholesale inventories for January are due for release today. In corporate news, Facet Biotech (NASDAQ:FACT) may be in the spotlight on news that Abbott Laboratories is purchasing the company for $722 million. The Children's Place Retail Stores (NASDAQ:PLCE) reported fiscal Q4 EPS of $1.03, ex-items,inline with consensus estimates. Revenues for the quarter rose 5% year-over-year to $462.8 million, inline with the consensus estimates. The Dow Jones Industrial Average (DJI) futures are trading 6.00 points above fair value, the S&P500 (INX) futures are trading 0.60 points above fair value, and the Nasdaq Composite (IXIC) futures are trading 3.25 points above fair value.
Nanotechnology research has been building up for some time, and is on the brink of revolutionizing industries from personal computing all the way up to cancer treatment. With the use of the latest market research, industry trends and statistics, CEO of Plunkett Research, Ltd.™, Jack W. Plunkett, recaps the history of the Nanotechnology business, discusses the areas of the world contributing most to the research and development and illustrates examples of both the current uses of nanotechnology and the future impacts this industry is going to have on every facet of our lives. As always, visit us at: www.facebook.com twitter.com and at www.plunkettresearch.com
From smartphones to skincare, there are currently over 1000 commercial products containing nanomaterials, with applications as far ranging as the fields of medicine, engineering, electronics and energy production. This session of Public Health Grand Rounds focuses on the current state of knowledge in nanotechnology and discusses concerns about the harmful impact that exposure to some nanomaterials may have on humans and the environment. Comments on this video are allowed in accordance with our comment policy: www.cdc.gov This video can also be viewed at www.cdc.gov
We take a little bit of a deeper look at the different vector methods of recombinant DNA practices. I explain to MrFacet why he's still wrong, and what's wrong with his "debate tactics," including how he prefers to guide the conversation to a "forum" of his choice, likes to use big talk that might intimidate a 15 year old, and pretends like I'm bluffing about the confidence in my stance as if calling me on it might be intimidating. I also explain how the single paper he linked me to wasn't all that great or scientifically accurate, and how sometimes, the occassional scientist will say something either outlandish, unfounded, or just outright incorrect. Jefferton also makes a couple cameos in this video! Haemoglobin in plants: www.nature.com The Foundation for Biotechnology Awareness and Education: www.fbae.org Pufferfish's dreaded paper: www.ncbi.nlm.nih.gov The Abstract that Frightened the Pufferfish Away: www.sciencedirect.com MrFacet's self portrait: www.andreaharner.com
|
|
